Researchers found that N-acylethanolamines derived from omega-3 fatty acids selectively activated CB2 cannabinoid receptors without activating CB1, potentially explaining part of omega-3s' well-known anti-inflammatory effects.
Read this if you are interested in how diet affects the endocannabinoid system and inflammation.
Omega-3 derived NAEs activated CB2 receptors selectively, without activating CB1
What the researchers found
The endocannabinoid system produces a family of signaling molecules called N-acylethanolamines (NAEs), of which anandamide is the most famous. Researchers systematically tested the full range of NAEs at cannabinoid and TRPV1 receptors and made a significant discovery about how dietary fatty acids connect to the endocannabinoid system.
NAEs derived from omega-6 fatty acids (including anandamide) activated both CB1 and CB2 receptors, making them full endocannabinoids. But NAEs derived from omega-3 fatty acids selectively activated CB2 receptors without activating CB1. Since CB2 receptors mediate anti-inflammatory effects without the psychoactive properties associated with CB1, this suggests a specific molecular pathway through which omega-3 fatty acids could produce anti-inflammatory benefits.
The researchers also found that commonly studied NAEs like PEA, SEA, and OEA are not endocannabinoids or endovanilloids at all. Their higher natural concentrations compared to polyunsaturated NAEs reflect slower breakdown rates rather than greater biological activity at cannabinoid receptors.
Why it matters
This study provides a molecular bridge between two major areas of health research: omega-3 fatty acids and the endocannabinoid system. If omega-3 derived endocannabinoids preferentially activate anti-inflammatory CB2 receptors, it could explain why diets high in omega-3 fatty acids are associated with reduced inflammation and why the omega-6 to omega-3 ratio in the diet matters for health.
The numbers in context
Omega-6 derived NAEs activated both CB1 and CB2 receptors plus TRPV1 channels. Omega-3 derived NAEs activated CB2 receptors only (some also activated TRPV1 but not CB1). PEA, SEA, and OEA were confirmed as non-endocannabinoids despite high endogenous concentrations. Higher concentrations of PEA/SEA/OEA reflected slower FAAH hydrolysis rates.
How the study worked
Researchers developed novel quantification assays to measure multiple NAEs in biological tissues and their rates of hydrolysis by fatty acid amide hydrolase (FAAH). The full range of NAEs was tested in rapid-response assays at CB1, CB2, and TRPV1 receptors to determine receptor selectivity profiles.
What this study cannot tell us
Receptor activation was tested in cell-based assays, and the in vivo significance of the CB2 selectivity of omega-3 NAEs remains to be confirmed. The study did not directly test whether dietary omega-3 supplementation changes the NAE profile in tissues enough to produce measurable anti-inflammatory effects. Concentrations effective in assays may not reflect physiological levels.
How to read the evidence
This is a laboratory receptor pharmacology study providing preliminary evidence for a novel connection between dietary fatty acids and endocannabinoid signaling.
When this study was published
Published in 2018. The diet-endocannabinoid connection continues to be an active research area.
The bigger picture
The connection between dietary fats and the endocannabinoid system could reshape how we think about both nutrition and cannabinoid medicine. If the ratio of omega-6 to omega-3 in the diet shifts the balance of endocannabinoid signaling toward CB1 versus CB2 activation, dietary interventions could potentially modulate endocannabinoid tone and inflammation.
Questions still open
- Does dietary omega-3 supplementation measurably shift endocannabinoid signaling toward CB2 in humans? Could omega-3 intake modulate the response to exogenous cannabinoids? Does the modern omega-6-heavy Western diet contribute to a pro-inflammatory endocannabinoid profile?
Common questions
Can eating omega-3s affect your endocannabinoid system?
Is PEA (palmitoylethanolamide) an endocannabinoid?
Read the original research
n-3 polyunsaturated N-acylethanolamines are CB2 cannabinoid receptor-preferring endocannabinoids.
Biochimica et biophysica acta. Molecular and cell biology of lipids, 1863(11), 1433-1440
Citation
Alharthi, Nahed; Christensen, Peter; Hourani, Wafa; Ortori, Catherine; Barrett, David A; Bennett, Andrew J; Chapman, Victoria; Alexander, Stephen P H. (2018). n-3 polyunsaturated N-acylethanolamines are CB2 cannabinoid receptor-preferring endocannabinoids.. Biochimica et biophysica acta. Molecular and cell biology of lipids, 1863(11), 1433-1440. https://doi.org/10.1016/j.bbalip.2018.08.003
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)